Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779

BACKGROUND: Tuberous Sclerosis Complex (TSC) is an autosomal dominant hamartoma disorder with variable expression for which treatment options are limited. TSC is caused by a mutation in either the TSC1 or TSC2 genes, whose products, hamartin and tuberin, function as negative regulators in the highly...

Descripción completa

Detalles Bibliográficos
Autores principales: Messina, Michael P, Rauktys, Aubrey, Lee, Laifong, Dabora, Sandra L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213639/
https://www.ncbi.nlm.nih.gov/pubmed/17986349
http://dx.doi.org/10.1186/1471-2210-7-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213639/
https://www.ncbi.nlm.nih.gov/pubmed/17986349
http://dx.doi.org/10.1186/1471-2210-7-14

Ejemplares similares